ArticleParasite (Paris, France)2026
Immunological surveillance using anti-gSG6-P1 IgG biomarker reveals spatio-temporal dynamics of Anopheles exposure and gaps in malaria risk assessment in the Greater Mekong Subregion.
Article in Parasite (Paris, France), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Entomological parameters such as mosquito biting rates often fail to capture variability in human behavior, thereby limiting its accuracy for assessing the population-level malaria risk. This study investigated the use of previously described Anopheles gambiae-based anti-salivary biomarker, anti-gSG6-P1, as a serological marker for Anopheles exposure, and examined key entomological, human, and environmental risk factors in Sisaket Province, Thailand. Blood samples were collected via finger prick from the same set of 184 participants across three seasons: rainy (August 2022), cool-dry (December 2022), and hot-dry (April 2023). Anti-gSG6-P1 IgG levels were quantified using ELISA. Factor Analysis of Mixed Data revealed that seasonality exerted the strongest influence on anti-gSG6-P1 IgG levels, which was likely driven by human activities, particularly the frequency of rubber tapping activity in the areas where Anopheles dirus is present. A higher frequency of rubber plot entry (5-7 days/week) significantly increased anti-gSG6-P1 IgG responses (1.08 ± 0.36) compared with the lower frequency group (0-4 days/week) (0.96 ± 0.35). Furthermore, our findings revealed the complex interplay between anti-gSG6-P1 IgG levels and the seasonality of human behavioral and vector dynamics. These factors highlight key limitations of the anti-gSG6-P1 IgG biomarker in the Greater Mekong Subregion, particularly the lack of well-characterized anti-gSG6-P1 IgG serological response kinetics in regions where predominant vector species exhibit low salivary peptide homology to An. gambiae. These findings emphasize the need for new serological tools tailored to malaria vector species present in the Subregion to improve malaria risk assessment and strengthen vector control strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.